International Products Law Review 2020: Issue 76

Published date13 January 2020
Subject MatterClass Action,Evidence,Appeals,Climate Change,Litigation Strategies,Carbon Emissions,Multidistrict Litigation,EU,Cybersecurity,Consent,Prescription Drugs,Causation,Vaccinations,Energy Efficiency,Project Management,Cookies,Regulatory Agenda,GlaxoSmithKline,Legislative Agendas,Disclosure,Business Litigation,Opt-In,Litigation Funding,Germany,European Court of Justice (ECJ),Pharmaceutical Industry,CJEU,Opioid,Consumer Protection Laws
AuthorEduardo Ustaran,Matthew Felwick,Omar Guerrero Rodríguez,Dr. Sebastian Polly,Joaquin Ruiz Echauri,Jorge Etreros Arnanz,Dr. Matthias Schweiger,Charles-Henri Caron,Marek Wroniak,Phoebe Wilkinson,Lloyd Parker,Christine Gateau,Christelle Coslin,Valerie Kenyon,John Meltzer,Francesca Rolla,Christian Di Mauro,Michael Kidney,Ina Brock,Dr. Marion Palmer,Carolina Revenga,Manon Cordewener,Alvin Lindsay,Lauren Colton,Katie McMullan,Adeela Khan,Magdalena Bakowska,Julie Schindel,Stefan Mayr, LL.M.
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT